$22.89
0.74% today
Nasdaq, Feb 28, 05:15 pm CET
ISIN
US4579852082
Symbol
IART

Integra LifeSciences Holdings Corporation Stock price

$23.06
-3.31 12.55% 1M
+2.54 12.38% 6M
+0.38 1.68% YTD
-21.21 47.91% 1Y
-44.00 65.61% 3Y
-29.71 56.30% 5Y
-4.06 14.97% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-0.54 2.29%
ISIN
US4579852082
Symbol
IART
Sector

Key metrics

Market capitalization $1.78b
Enterprise Value $3.49b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 139.89
EV/Sales (TTM) EV/Sales 2.17
P/S ratio (TTM) P/S ratio 1.11
P/B ratio (TTM) P/B ratio 1.15
Revenue growth (TTM) Revenue growth 4.47%
Revenue (TTM) Revenue $1.61b
EBIT (operating result TTM) EBIT $131.72m
Free Cash Flow (TTM) Free Cash Flow $24.96m
Cash position $273.57m
EPS (TTM) EPS $-0.09
P/E forward 24.71
P/S forward 1.06
EV/Sales forward 2.08
Short interest 5.11%
Show more

Is Integra LifeSciences Holdings Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Integra LifeSciences Holdings Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:

2x Buy
17%
6x Hold
50%
4x Sell
33%

Analyst Opinions

12 Analysts have issued a Integra LifeSciences Holdings Corporation forecast:

Buy
17%
Hold
50%
Sell
33%

Financial data from Integra LifeSciences Holdings Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,611 1,611
4% 4%
100%
- Direct Costs 677 677
12% 12%
42%
934 934
0% 0%
58%
- Selling and Administrative Expenses 564 564
11% 11%
35%
- Research and Development Expense 97 97
18% 18%
6%
273 273
20% 20%
17%
- Depreciation and Amortization 141 141
14% 14%
9%
EBIT (Operating Income) EBIT 132 132
40% 40%
8%
Net Profit -6.94 -6.94
110% 110%
0%

In millions USD.

Don't miss a Thing! We will send you all news about Integra LifeSciences Holdings Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Integra LifeSciences Holdings Corporation Stock News

Neutral
GlobeNewsWire
3 days ago
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Corp. (NASDAQ: IART) on behalf of long-term stockholders following a class action complaint that was filed against Integra on September 12, 2023 with a Class Period from March 11, 2019 to May 22, 202...
Neutral
Seeking Alpha
3 days ago
Integra LifeSciences Holdings Corporation (IART) Q4 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
3 days ago
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024.
More Integra LifeSciences Holdings Corporation News

Company Profile

Integra LifeSciences Holdings Corp. engages in the manufacture and sale of medical instruments, devices, and equipment. It operates through the Codman Specialty Surgical, and Orthopedics and Tissue Technologies segments. The Codman Specialty Surgical segment refers to the company's neurosurgery business, which sells a full line of products for neurosurgery and neuro critical care such as tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and precision tools and instruments business, which sells instrument patterns and surgical and lighting products to hospitals, surgery centers, and dental, podiatry, and veterinary offices. The Orthopedics and Tissue Technologies segment includes offerings such as skin and wound repair, bone and joint fixation implants in the upper and lower extremities, bone grafts, and nerve and tendon repair. The company was founded by Richard E. Caruso in 1989 and is headquartered in Princeton, NJ.

Head office United States
CEO Mojdeh Poul
Employees 4,396
Founded 1989
Website www.integralife.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today